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Abstract
Background
Given the dramatic increase in type 2 diabetes in the
United States, the development of effective strategies to
prevent and control this potentially devastating illness is
more important than ever. In the Southwest, diabetes is a
far too common and rapidly growing problem among
Mexican Americans living near the U.S.-Mexico border. A
project designed to address this problem enabled faculty
from the University of Arizona to work with community
health centers to evaluate and improve diabetes care in
border communities.
Context
This project was a component of the Border Health
Strategic Initiative (Border Health ¡SI!) and Racial
and Ethnic Approaches to Community Health 2010
(REACH 2010), both funded by the Centers for Disease
Control and Prevention. University of Arizona faculty
worked in partnership with five community health cen-
ters funded by the Health Resources and Services
Administration. The goal of the faculty was to assist
the community health centers with 1) development of
measures of diabetes care based on national clinical
practice guidelines, 2) identification of gaps in care
based on those measures, and 3) implementation of
strategies for closing those gaps.
Methods
All five centers prioritized their top four or five 
indicators of diabetes care (e.g., annual dilated eye
examination). Different community health centers
selected different indicators. Baseline medical record
audits were performed using the chosen indicators.
Individual results were shared confidentially with
providers; overall center results were shared and dis-
cussed with providers and staff.
Consequences
Each clinic chose its own strategies for closing gaps in
care. At one-year follow-up, there was evidence of improve-
ment for the majority of indicators in all community health
centers. However, some gaps remained. Of the three com-
munity health centers having a second-year evaluation,
two maintained or increased the improvements made, but
one lost ground.
Interpretation
Our experience with these five border clinics was that
translating guidelines into practice is easier said than
done. Factors that favored success included an onsite
champion, staff buy-in, a willingness to see systems
change, and the availability of additional resources, par-
ticularly for chart reviews.
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Background
Between 1990 and 2000, the Mexican population in the
United States increased by 52.9%, from 13.5 million to
20.6 million. By 2050, it is estimated that there will be 97
million Hispanic Americans in the United States, com-
prising about one quarter of the total population (1). In
2000, more than 43% of Hispanics lived in the West. Half
of all Hispanics lived in just two states, California and
Texas. The largest Mexican populations were in California,
Texas, Illinois, and Arizona. In the three border states
(California, Texas, and Arizona), Hispanics were in the
majority in 50 counties along the U.S.-Mexico border (2). 
Diabetes was the sixth leading cause of death in the
United States in the year 2000. More than 17 million
Americans (about 2 million Hispanic Americans) have
been diagnosed with diabetes, and approximately 1 million
more individuals, aged 20 years and older, are diagnosed
with diabetes each year (3). At any given age, Mexican
Americans are twice as likely to have type 2 diabetes as
non-Hispanic whites (4).
In 2002, researchers at the Centers for Disease Control
and Prevention (CDC) developed a Diabetes Report Card
to examine quality of diabetes care in the United States
during the 1990s based on nationally accepted guidelines
for care. Their research revealed that 18% of persons with
diabetes aged 18 to 75 years had very poor glycemic con-
trol (HbA1c values >9.5%) and that 34% had elevated
blood pressures ($140/90 mm Hg). Left untreated or inad-
equately treated, both conditions will lead to increased
morbidity and mortality (3). Additionally, 45% of patients
with diabetes had not had a foot examination during the
previous year and 37% had not had a dilated eye exam (3).
In a September 2004 report on the quality of care
among its member health plans, The National Committee
for Quality Assurance (NCQA) asserts that many
Americans do not receive adequate preventive care and/or
care for chronic conditions like diabetes and hypertension.
It further asserts that the gap between the less-than-opti-
mal health care that most Americans receive and the care
that some receive from the best health plans results in
anywhere between 42,000 and 79,000 premature deaths
per year (5).
There is increasing evidence of the kinds of programs
and treatment strategies that are effective in controlling
diabetes and preventing its complications; however, the
translation of that evidence into medical practice contin-
ues to lag. The Institute of Medicine estimates that the
time between the discovery of an effective treatment and
its incorporation into routine care is as long as 17 years
and that more than 50% of patients with such common
conditions as diabetes, hypertension, tobacco addiction,
hyperlipidemia, congestive heart failure, asthma,
depression, and chronic atrial fibrillation are inade-
quately managed (6).
Context
Community Health Centers (CHCs) first received fed-
eral funding as part of the War on Poverty in the mid-
1960s. Approximately 100 CHCs (known at the time as
neighborhood health centers) had been funded under the
Economic Opportunity Act (EOA) by the early 1970s.
These centers made culturally appropriate health care
accessible to many low-income families. In 1969, the
Public Health Service (PHS) also began funding neigh-
borhood health centers. When the EOA was phased out
in the early 1970s, centers previously supported under it
were transferred to the Public Health Service (PHS).
Today, CHC funding is authorized under section 330 of
the PHS Act through the Health Resources & Services
Administration (HRSA). CHCs exist in areas where eco-
nomic, geographic, or cultural barriers limit access to
primary health care. Their mission is to provide family-
oriented, primary, and preventive health care services
for people living in rural and urban medically under-
served communities (7).
This paper describes our experiences as university fac-
ulty with the primary care providers (medical doctors, doc-
tors of osteopathy, nurse practitioners, and physician
assistants) and support staff in five community health cen-
ters participating in two federally funded projects, The
Border Health Strategic Initiative (Border Health ¡SI!)
and Racial and Ethnic Approaches to Community Health
2010 (REACH 2010). All five centers are located in the
United States near the U.S.-Mexico border and care for
large Hispanic populations with a high prevalence of dia-
betes. The border region includes four states in the United
States (Arizona, California, New Mexico, and Texas) and
six states in Mexico (Baja California, Chihuahua,
Coahuila, Nuevo Leon, Sonora, and Tamaulipas). 
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sides of the border — 6,268,107 individuals on the U.S.
side, and 5,054,516 on the Mexico side (8). The U.S. side is
approximately 70% Hispanic, with a higher population
growth rate (1.8%) than the national rate (0.9%). Five of
the seven poorest counties in the United States are on the
border, and more than 30% of Hispanics living on the bor-
der are uninsured (9).
Methods
In all five centers, we met with the medical directors and
other clinical management staff. First, we explained the
project and our approach. Next, we worked with medical
directors to develop target guidelines, or indicators. We
used an “indicators of care” form to help them identify five
aspects of diabetes care they most valued. We limited the
medical directors to five aspects out of concern that they
might try to accomplish too much, too soon. One center
tracked only four indicators after a mid-course change. We
encouraged the medical directors to involve their medical
and other health care staff in this selection process, and we
had conversations with the medical directors and/or their
staff about their choices, especially when there was not
good evidence to support a selected intervention or inter-
vention frequency. However, the centers’ choices always
prevailed, even if they selected a measure for which there
was not good evidence. Some medical directors were more
interested than others, some had more participatory man-
agement styles than others, and some delegated more
than others. We adapted our procedures to the local char-
acteristics of each center. Each CHC was given the option
of having record reviews performed and reported only at
the center level or at both the center and provider levels,
with the provider-level results being shared confidentially
with individual providers. All CHCs opted for both
provider and center-level results.
Primary care providers for each clinic were eligible to
have their patients’ charts included in the record review if
the provider had practiced at the CHC for the 12 months
prior to the review. Not all providers at each CHC partici-
pated in this project. In some CHCs with multiple offices,
participation was limited to one site. In addition, while
many of the same providers participated from the begin-
ning to the end of the project, staff turnover led to changes
in those individuals being reviewed from one year to the
next. As planned, we completed three rounds of data col-
lection (baseline, one-year follow-up, and two-year follow-
up) in three clinics and two rounds (baseline, one-year fol-
low-up) in the other two. In 2001, we audited 22 providers’
records from five participating CHCs; in 2002, 19
providers’ records from five CHCs; and in 2003, nine
providers’ records from three CHCs.
After indicators were selected, we developed indicator-
specific training manuals for medical records reviewers.
The manual was designed to allow us to train staff with lit-
tle or no medical records review experience and to serve as
a reference for questions reviewers might have during the
review process. Reviewers were instructed to begin audit-
ing charts soon after their training was completed. Charts
were randomly selected from up-to-date listings of patients
with diabetes assigned to each primary provider. For a
chart to be eligible, the patient had to be at least 18 years
of age, had to have a diagnosis of diabetes based on
Current Procedural Terminology 250.XX codes, and had to
have visited his/her primary provider at least once during
the 12 months under review. If there were multiple visits
during the 12 months, the primary provider had to have
seen the patient for a majority of those visits. 
Obtaining provider-level data required a larger sample
than would have been necessary for clinic-level data.
Evidence from prior studies indicated that 12 to 15 charts
per provider are needed to obtain a stable estimate of
provider performance while imposing the lowest possible
burden on center staff. To ensure and improve the 
reliability of our reviewers, we used two reviewers in every
center for each review cycle, asking that they assign a pri-
mary and secondary reviewer for each provider’s records.
The primary reviewer reviewed all of that provider’s
records. The secondary reviewer randomly selected and
reviewed two of that provider’s records while avoiding dis-
cussing them with the primary reviewer and/or viewing
his/her audit results. The secondary reviewer was then
instructed to compare both reviews and mark all inconsis-
tencies on the secondary review form. Both reviewers were
then asked to review the disagreements and, where indi-
cated, correct any mistakes on the primary review form.
The primary review forms were used to calculate the level
of compliance with selected indicators. The marked sec-
ondary review forms, which showed primary and second-
ary reviewer errors, were used to calculate interrater
agreement. Our goal was to achieve interrater agreement
of greater than or equal to 90%. We missed that mark only
twice in a total of thirteen reviews. The chart selection
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process was repeated for each round of reviews. These
cross-sectional samples included only those randomly
selected patients who met eligibility criteria for that year.
Following the initial reviews, we met with the medical
and key office staff to present a table showing baseline cen-
ter-level results. All participants received their CHC’s
results. Each individual provider also received a table in a
sealed envelope comparing his/her results to center
results. We promised a repeat audit in about 12 months.
We returned to reaudit charts, as promised, in approxi-
mately 12 months for two centers and in both 12 and 24
months for three centers. After each audit, we presented
our results to the medical staff and discussed strategies for
further improvement. In the satellite center that showed
the least improvement at year one, we changed some indi-
cators at the request of the primary provider, who had dif-
ferent priorities for diabetes care and had not been able to
participate in the initial selection process.
Consequences
For most indicators, overall center performance was
higher at the one-year assessment than it was at baseline.
In addition, two of the three CHCs having year-two assess-
ments showed generally improved results from year one.
The third center’s year-two results showed worsening per-
formance in most areas compared with year one. Given the
cross-sectional nature of the samples, these results should
be interpreted with caution.
Only two of the five centers prioritized the same five dia-
betes indicators, and only two indicators were selected by
all five CHCs — namely, annual assessment of urine for
microalbuminuria and HbA1c testing. For HbA1c testing,
there were differences in the desired frequency, with some
CHCs wanting at least two HbA1c tests per year and oth-
ers wanting three tests per year. Factors that seemed to
influence indicator selection and adherence included
whether the selection was based on consensus or made by
the medical director; provider training, experience, and
beliefs; and CHC staff and organizational issues. In one
CHC where the medical director chose the indicators, we
later revised them midstream to reflect the priorities of a
physician who had not been involved in the initial process
and was the sole CHC physician participant in our initia-
tive. From this experience and others, we learned that it
was important to recognize and address local issues that
could adversely affect indicator selection and/or staff buy-
in and participation.
All five of our CHCs used paper records. While there is
evidence that provider reminder systems such as diabetes
flow sheets helped improve diabetes care, not all of our
centers used them (10,11). Some were understandably
resistant to adding yet another flow sheet to their already
complicated charts. One CHC already had incorporated its
diabetes measures into its adult health maintenance flow
sheet. The majority of its patients did not have diabetes,
and providers were only infrequently using that portion of
the flow sheet. After some discussion, we arrived at the
solution of placing colored stickers inside the charts on the
adult health maintenance/diabetes flow sheets of their
patients with diabetes. This change resulted in improved
recognition of patients with diabetes and improved 
performance on the indicators. The use of flow sheets, 
in general, was associated with improved recognition 
and performance.
Any new initiative dependent on the participation of
providers must compete with many other demands on
their time during usual patient encounters (e.g., patient
expectations and requests, professional concerns, diverse
and sometimes conflicting practice guidelines and preven-
tion recommendations, local and national initiatives,
interruptions, emergencies). For example, even though
four of our five partner CHCs were participating in the
HRSA/CDC Diabetes Collaborative — whose members
agreed to adopt local shared quality-improvement meas-
ures consistent with national guidelines — the level of
participation still varied considerably from site to site.
This taught us that participation in other diabetes pro-
grams was no guarantee of success.
In most centers, providers reacted to our initial presen-
tation of results with disbelief, as both their individual and
CHC levels of compliance were typically lower than they
expected. During our meeting, they appeared to be com-
paring their results with center results and sometimes
with another provider’s results. We addressed the skepti-
cism in several ways. First, we described our methods dur-
ing our presentation (i.e., the comprehensiveness of the
chart reviews, the use of two reviewers for quality control,
the levels of interrater reliability). Second, we also asked
the reviewers, who could be project and/or local office staff,
to be present to respond to any questions. Third, we put
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with available national statistics that were typically
about the same or worse. Generally, these strategies
overcame barriers to acceptance, and we were able to
move on to a more substantive discussion on what steps
could be taken for improvement. We then facilitated dis-
cussions on what behavioral and structural changes
providers could make as a staff to improve their results,
and we offered technical assistance, such as help with
the development of flow sheets or telephone consulta-
tion. By the end of the meeting, centers had usually
developed a tentative plan for improvement. From this,
we concluded that while obtaining provider-level data
was more work, it generated a healthy interest and
sense of competition among participants.
Given how busy providers often are, we looked for other
ways to improve care. When feasible, we recommended
implementing measures via “systems change” as an alter-
native to assigning a new responsibility to already over-
burdened providers. In one center, the medical director
agreed with our recommendation that medical assistants
take more responsibility for charting and ordering certain
diabetes screening tests under standing orders, such as
annual urine testing for microalbumin, annual lipid panel,
and periodic HbA1c testing. We conducted a special train-
ing session for those staff. However, it took several visits
before we noticed a change, and we were not confident that
it would persist. We learned from this and other experi-
ences that systems change at the practice level can be
quite difficult to achieve and sustain.
Interpretation
Despite the many competing demands on CHCs, our
project did achieve some success, and we believe that it
was worthwhile. We helped the CHCs focus on interven-
tions that matter but are sometimes neglected. Our CHCs
often chose indicators based on national guidelines. They
were motivated to review and, in many cases, improve
their performances, thereby closing the gap that exists
between research and practice. Three CHCs elected to con-
tinue beyond their original three-year commitment. For
the CHCs that chose not to continue after their initial com-
mitment, the availability of resources, particularly for
medical audits, was an important issue.
We want to be careful about generalizing, since we
worked with only five CHCs and no two were alike.
Further, as consultants, we were not always privy to the
activities and interventions that took place between our
visits. Nonetheless, we observed that six factors were most
important to overall success in our initiative: 1) the pres-
ence of an onsite champion, 2) broad staff and managerial
support and participation, 3) the willingness of providers
to delegate authority to ancillary staff via standing orders
for routine tasks and testing, 4) the use of flow sheets, 5)
the presence of a full-service diabetes clinic, and 6) access
to provider-level data. In our experience, these are the 
factors that most favor success. We hope that these 
observations will prove useful to those contemplating 
similar initiatives.
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